Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postoperative vaginal cuff irradiation using high dose rate remote afterloading: a phase II clinical protocol

W R Noyes1, K Bastin, S A Edwards

  • 1Department of Human Oncology, University of Wisconsin Medical School, Madison 53792, USA.

International Journal of Radiation Oncology, Biology, Physics
|July 30, 1995
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hand eczema in children referred for patch testing: North American Contact Dermatitis Group Data, 2000-2016.

The British journal of dermatology·2021
Same author

Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switches.

The British journal of dermatology·2018
Same author

Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Hyperfractionated radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2014
Same author

The effect of multiple small doses of X rays on skin reactions in the mouse and a basic interpretation. 1976.

Radiation research·2012
Same author

Development of an adjoint sensitivity field-based treatment-planning technique for the use of newly designed directional LDR sources in brachytherapy.

Physics in medicine and biology·2012

High dose rate (HDR) brachytherapy shows promising local control for endometrial cancer patients. This Phase II study indicates HDR vaginal cuff treatment is well-tolerated with minimal recurrence, suggesting comparable outcomes to low dose rate (LDR) brachytherapy.

Area of Science:

  • Gynecology
  • Radiation Oncology
  • Oncology

Background:

  • Endometrial adenocarcinoma requires effective postoperative treatment to improve survival and prevent recurrence.
  • High dose rate (HDR) brachytherapy is an evolving technique for localized cancer treatment.
  • International Federation of Gynecology and Obstetrics (FIGO) staging is crucial for treatment stratification.

Purpose of the Study:

  • To evaluate the efficacy and safety of a Phase II HDR brachytherapy protocol for postoperative FIGO Stage I endometrial adenocarcinoma.
  • To report overall survival, local control rates, and complication profiles in patients treated with HDR vaginal cuff brachytherapy.
  • To compare preliminary HDR brachytherapy outcomes with existing low dose rate (LDR) brachytherapy data.

Main Methods:

Related Experiment Videos

  • A Phase II study involving 63 patients with FIGO Stage I endometrial adenocarcinoma.
  • Postoperative HDR brachytherapy using an Iridium-192 remote afterloader.
  • Two vaginal cuff treatments of 32.4 Gy in two fractions, delivered 1 week apart, using vaginal ovoids.

    • Main Results:

    • No vaginal cuff recurrences observed in 63 patients at a median follow-up of 1.6 years.
    • One regional recurrence (1.6%) occurred, treated successfully with salvage irradiation.
    • Vaginal apex fibrosis occurred in 22% of patients, symptomatic in 6.3%; vaginal stenosis in 1.6%.

    Conclusions:

    • Preliminary results suggest 32.4 Gy in two fractions of HDR vaginal cuff brachytherapy is well-tolerated for early-stage endometrial cancer.
    • Local control appears comparable to LDR brachytherapy, warranting further investigation.
    • Continued patient accrual and follow-up are necessary to fully assess late morbidity, local control, and overall survival.